W
William Small
Researcher at Loyola University Chicago
Publications - 423
Citations - 15241
William Small is an academic researcher from Loyola University Chicago. The author has contributed to research in topics: Radiation therapy & Brachytherapy. The author has an hindex of 56, co-authored 396 publications receiving 12744 citations. Previous affiliations of William Small include University of Hong Kong & University of Chicago.
Papers
More filters
Journal ArticleDOI
Primary gastrointestinal sarcomas: analysis of prognostic factors and results of surgical management.
Katharine Yao,Mark S. Talamonti,Rosa L. Langella,Nancy Schindler,Sambasiva Rao,William Small,Raymond J. Joehl +6 more
TL;DR: In this article, the authors reviewed the clinical presentation, surgical management, and prognostic factors for primary gastrointestinal sarcomas from 1981 through 1996, and found that the stomach was the most common site of disease, followed by the small intestine.
Journal ArticleDOI
Clinical trials in low and middle-income countries - Successes and challenges.
Surbhi Grover,Melody J. Xu,Anuja Jhingran,Umesh Mahantshetty,Linus Chuang,William Small,David K. Gaffney +6 more
TL;DR: The challenges involved in initiating clinical trials in LMICs are described, current efforts within surgical, medical, and radiation oncology are reviewed, and high priority topics for future research are introduced.
Journal Article
Brain metastasis in gestational trophoblastic neoplasia: an update.
Nikki L. Neubauer,Nawar A. Latif,K. Kalakota,Maryanne H. Marymont,William Small,Julian C. Schink,John R. Lurain +6 more
TL;DR: Brain metastases in GTN are curable with a combination of systemic multiagent chemotherapy and whole brain irradiation, and no patient who died had uncontrolled brain metastases.
Journal ArticleDOI
Postradiotherapy pelvic fractures: cause for concern or opportunity for future research?
William Small,Lisa A. Kachnic +1 more
Journal ArticleDOI
Molecular markers and prediction of response to chemoradiation in rectal cancer
Adaora Okonkwo,Srinidhi Musunuri,Mark S. Talamonti,A. L. Benson,William Small,Steven J. Stryker,M. Sambasiva Rao +6 more
TL;DR: Level of TS in tumors is the best predictor of sensitivity or resistance to chemoradiation, and no such correlation between overexpression of p53 and Bcl-2 and response to cheMoradiation is observed.